Literature DB >> 2166911

Neuromuscular transmission in the mdx mouse.

A Nagel1, F Lehmann-Horn, A G Engel.   

Abstract

In both disorders, the muscle fiber plasma membrane is rendered selectively vulnerable by dystrophin deficiency. In both disorders there are also ultrastructural abnormalities involving the postsynaptic membrane of the neuromuscular junction. The object of this electrophysiologic study was to determine whether the observed ultrastructural abnormalities at the mdx neuromuscular junction are associated with an abnormality of neuromuscular transmission. In comparison with age-matched control mice, the mdx mice show an abnormal, age-dependent decrease of the amplitude of the miniature end-plate potential and a concomitant increase in the quantal content of the end-plate potential. Consequently, the safety margin of neuromuscular transmission is not impaired.

Entities:  

Mesh:

Year:  1990        PMID: 2166911     DOI: 10.1002/mus.880130813

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 2.  Invaginating Presynaptic Terminals in Neuromuscular Junctions, Photoreceptor Terminals, and Other Synapses of Animals.

Authors:  Ronald S Petralia; Ya-Xian Wang; Mark P Mattson; Pamela J Yao
Journal:  Neuromolecular Med       Date:  2017-06-13       Impact factor: 3.843

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 4.  Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres.

Authors:  Bruno Allard
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

5.  Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice.

Authors:  Dean J Burkin; Gregory Q Wallace; Derek J Milner; Eric J Chaney; James A Mulligan; Stephen J Kaufman
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  Innervation of dystrophic muscle after muscle stem cell therapy.

Authors:  Matthew Tierney; Christina Garcia; Matthew Bancone; Alessandra Sacco; Kirkwood E Personius
Journal:  Muscle Nerve       Date:  2016-08-17       Impact factor: 3.217

7.  Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.

Authors:  Patrick E Baker; Jessica A Kearney; Bendi Gong; Anita P Merriam; Donald E Kuhn; John D Porter; Jill A Rafael-Fortney
Journal:  Neurogenetics       Date:  2006-03-09       Impact factor: 2.660

8.  Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.

Authors:  Jarrod A Call; Gordon L Warren; Mayank Verma; Dawn A Lowe
Journal:  J Physiol       Date:  2013-06-10       Impact factor: 5.182

9.  Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Meredith Oltmann; Chiara Rinaldi; Kyu H Myung; James G Tidball
Journal:  Hum Mol Genet       Date:  2009-06-19       Impact factor: 6.150

Review 10.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.